Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CRHBP | P24387 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.39 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 13/20 | 0.37 |
| ▸ | HSD11B2 | P80365 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14768238 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| SCHEMBL1032965 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| SCHEMBL1032963 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| SCHEMBL1032964 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| SCHEMBL176523 | 0.82 | ALDH1A1 (0.52) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| SCHEMBL6877661 | 0.82 | ALDH1A1 (0.52) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| SCHEMBL1033374 | 0.81 | KDM4E (0.37) | ALDH1A1HTTHSD11B1HSD11B2TSHR | |
| SCHEMBL7627478 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| Hydrochloric Acid SCHEMBL7936029 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CRHBPHTTCRHR2MCOLN3 | |
| SCHEMBL16038530 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8828985-B2 | Carbamate and urea inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | VITAE PHARMACEUTICALS, INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-20130244994-A1 | CARBAMATE AND UREA INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 | CLAREMON DAVID A (US) | 2013-09-19 | — | — | US | disclosed |
| US-8399504-B2 | Carbamate and urea inhibitors of 11Beta-hydroxysteroid dehydrogenase 1 | VITAE PHARMACEUTICALS, INC. (US) | 2013-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130244994-A1 | CARBAMATE AND UREA INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 | HSD11B1, HSD3B1, HSD17B1 | ALDH1A1 236/4885CRHBP 429/4885HTT 2995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.